<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on May 11, 2026 at 5:53 PM by All in One SEO v4.9.6.2 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://cgxpwire.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>cGxP.wire</title>
		<link><![CDATA[https://cgxpwire.com]]></link>
		<description><![CDATA[cGxP.wire]]></description>
		<lastBuildDate><![CDATA[Sat, 09 May 2026 06:47:13 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://cgxpwire.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/beacon-therapeutics-reports-positive-xlrp-gene-therapy-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/beacon-therapeutics-reports-positive-xlrp-gene-therapy-data/]]></link>
			<title>Beacon Therapeutics Reports Positive XLRP Gene Therapy Data</title>
			<pubDate><![CDATA[Sat, 09 May 2026 06:47:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/alpha-tau-completes-enrollment-in-pivotal-restart-cscc-study/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/alpha-tau-completes-enrollment-in-pivotal-restart-cscc-study/]]></link>
			<title>Alpha Tau Completes Enrollment in Pivotal ReSTART cSCC Study</title>
			<pubDate><![CDATA[Mon, 11 May 2026 07:46:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/actio-biosciences-initiates-kyron-phase-1b-2-trial-for-kcnt1-related-epilepsy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/actio-biosciences-initiates-kyron-phase-1b-2-trial-for-kcnt1-related-epilepsy/]]></link>
			<title>Actio Biosciences Initiates KYRON Phase 1b/2 Trial for KCNT1-Related Epilepsy</title>
			<pubDate><![CDATA[Mon, 11 May 2026 07:31:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/incyte-opzelura-shows-durable-atopic-dermatitis-benefit/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/incyte-opzelura-shows-durable-atopic-dermatitis-benefit/]]></link>
			<title>Incyte Opzelura Shows Durable Atopic Dermatitis Benefit</title>
			<pubDate><![CDATA[Sat, 09 May 2026 06:29:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/azalea-therapeutics-unveils-first-ever-in-vivo-trac-car-t-cell-engineering-breakthrough-at-asgct-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/azalea-therapeutics-unveils-first-ever-in-vivo-trac-car-t-cell-engineering-breakthrough-at-asgct-2026/]]></link>
			<title>Azalea Therapeutics Unveils First-Ever In Vivo TRAC-CAR T Cell Engineering Breakthrough at ASGCT 2026</title>
			<pubDate><![CDATA[Mon, 11 May 2026 07:14:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/government/fda-releases-pregnancy-safety-guidance-for-drugs-and-biologics/]]></guid>
			<link><![CDATA[https://cgxpwire.com/government/fda-releases-pregnancy-safety-guidance-for-drugs-and-biologics/]]></link>
			<title>FDA Releases Pregnancy Safety Guidance for Drugs and Biologics</title>
			<pubDate><![CDATA[Mon, 11 May 2026 06:52:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/caris-life-sciences-files-ny-approval-for-caris-assure/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/caris-life-sciences-files-ny-approval-for-caris-assure/]]></link>
			<title>Caris Life Sciences Files NY Approval for Caris Assure</title>
			<pubDate><![CDATA[Mon, 11 May 2026 06:49:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/biorestorative-therapies-reports-strong-phase-2-brtx-100-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/biorestorative-therapies-reports-strong-phase-2-brtx-100-data/]]></link>
			<title>BioRestorative Therapies Reports Strong Phase 2 BRTX-100 Data</title>
			<pubDate><![CDATA[Sat, 09 May 2026 06:31:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/longeveron-reports-constructive-fda-meeting-ahead-of-elpis-ii-hlhs-data-readout/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/longeveron-reports-constructive-fda-meeting-ahead-of-elpis-ii-hlhs-data-readout/]]></link>
			<title>Longeveron Reports Constructive FDA Meeting Ahead of ELPIS II HLHS Data Readout</title>
			<pubDate><![CDATA[Mon, 11 May 2026 06:40:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/technology/persistent-strengthens-life-sciences-ai-through-databricks/]]></guid>
			<link><![CDATA[https://cgxpwire.com/technology/persistent-strengthens-life-sciences-ai-through-databricks/]]></link>
			<title>Persistent Strengthens Life Sciences AI Through Databricks</title>
			<pubDate><![CDATA[Mon, 11 May 2026 06:41:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/halozyme-and-gsk-partner-on-next-gen-adc-cancer-therapies/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/halozyme-and-gsk-partner-on-next-gen-adc-cancer-therapies/]]></link>
			<title>Halozyme and GSK Partner on Next-Gen ADC Cancer Therapies</title>
			<pubDate><![CDATA[Mon, 11 May 2026 06:27:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/glucotrack-announces-fda-ide-submission-for-implantable-continuous-blood-glucose-monitoring-technology/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/glucotrack-announces-fda-ide-submission-for-implantable-continuous-blood-glucose-monitoring-technology/]]></link>
			<title>Glucotrack Announces FDA IDE Submission for Implantable Continuous Blood Glucose Monitoring Technology</title>
			<pubDate><![CDATA[Sat, 09 May 2026 06:19:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/mabwell-wins-fda-ind-clearance-for-9mw5211-in-ibd/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/mabwell-wins-fda-ind-clearance-for-9mw5211-in-ibd/]]></link>
			<title>Mabwell Wins FDA IND Clearance for 9MW5211 in IBD</title>
			<pubDate><![CDATA[Mon, 11 May 2026 06:12:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/argenx-gains-fda-approval-expanding-vyvgart-to-all-gmg-patients/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/argenx-gains-fda-approval-expanding-vyvgart-to-all-gmg-patients/]]></link>
			<title>Argenx Gains FDA Approval Expanding VYVGART to All gMG Patients</title>
			<pubDate><![CDATA[Mon, 11 May 2026 06:08:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/government/fda-approves-bizengri-for-rare-cholangiocarcinoma/]]></guid>
			<link><![CDATA[https://cgxpwire.com/government/fda-approves-bizengri-for-rare-cholangiocarcinoma/]]></link>
			<title>FDA Approves Bizengri for Rare Cholangiocarcinoma</title>
			<pubDate><![CDATA[Mon, 11 May 2026 05:45:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/alpha-tau-moves-closer-to-fda-clearance-for-alpha-dart/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/alpha-tau-moves-closer-to-fda-clearance-for-alpha-dart/]]></link>
			<title>Alpha Tau Moves Closer to FDA Clearance for Alpha DaRT</title>
			<pubDate><![CDATA[Mon, 11 May 2026 05:37:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/ensoma-presents-initial-en-374-clinical-safety-data-at-asgct-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/ensoma-presents-initial-en-374-clinical-safety-data-at-asgct-2026/]]></link>
			<title>Ensoma Presents Initial EN-374 Clinical Safety Data at ASGCT 2026</title>
			<pubDate><![CDATA[Mon, 11 May 2026 05:31:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/atsena-therapeutics-reports-positive-gene-therapy-data-at-arvo-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/atsena-therapeutics-reports-positive-gene-therapy-data-at-arvo-2026/]]></link>
			<title>Atsena Therapeutics Reports Positive Gene Therapy Data at ARVO 2026</title>
			<pubDate><![CDATA[Sat, 09 May 2026 06:06:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/medit-enters-new-growth-phase-with-progressive-orthodontics/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/medit-enters-new-growth-phase-with-progressive-orthodontics/]]></link>
			<title>Medit Enters New Growth Phase With Progressive Orthodontics</title>
			<pubDate><![CDATA[Mon, 11 May 2026 05:25:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/servier-advances-ojemda-front-line-brain-cancer-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/servier-advances-ojemda-front-line-brain-cancer-trial/]]></link>
			<title>Servier Advances OJEMDA Front-Line Brain Cancer Trial</title>
			<pubDate><![CDATA[Mon, 11 May 2026 05:08:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/inhibrx-reports-progress-for-inbrx-106-in-hnscc-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/inhibrx-reports-progress-for-inbrx-106-in-hnscc-trial/]]></link>
			<title>Inhibrx Reports Progress for INBRX-106 in HNSCC Trial</title>
			<pubDate><![CDATA[Mon, 11 May 2026 04:59:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/technology/persistent-launches-ai-innovation-lab-with-iit-kharagpur/]]></guid>
			<link><![CDATA[https://cgxpwire.com/technology/persistent-launches-ai-innovation-lab-with-iit-kharagpur/]]></link>
			<title>Persistent Launches AI Innovation Lab With IIT Kharagpur</title>
			<pubDate><![CDATA[Sat, 09 May 2026 07:28:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/coretissue-bioengineering-initiates-randomized-acl-reconstruction-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/coretissue-bioengineering-initiates-randomized-acl-reconstruction-trial/]]></link>
			<title>CoreTissue BioEngineering Initiates Randomized ACL Reconstruction Trial</title>
			<pubDate><![CDATA[Mon, 11 May 2026 04:56:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/alx-oncology-reports-durable-her2-breast-cancer-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/alx-oncology-reports-durable-her2-breast-cancer-data/]]></link>
			<title>ALX Oncology Reports Durable HER2 Breast Cancer Data</title>
			<pubDate><![CDATA[Sat, 09 May 2026 07:10:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/technology/mission-bio-unveils-single-cell-crispr-t-cell-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/technology/mission-bio-unveils-single-cell-crispr-t-cell-data/]]></link>
			<title>Mission Bio Unveils Single-Cell CRISPR T Cell Data</title>
			<pubDate><![CDATA[Sat, 09 May 2026 07:02:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/eisai-and-biogen-receive-fda-extension-for-leqembi/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/eisai-and-biogen-receive-fda-extension-for-leqembi/]]></link>
			<title>Eisai and Biogen Receive FDA Extension for LEQEMBI</title>
			<pubDate><![CDATA[Sat, 09 May 2026 06:55:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/trexbio-reports-new-trb-061-data-for-atopic-dermatitis/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/trexbio-reports-new-trb-061-data-for-atopic-dermatitis/]]></link>
			<title>TRexBio Reports New TRB-061 Data for Atopic Dermatitis</title>
			<pubDate><![CDATA[Sat, 09 May 2026 06:50:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/bausch-lomb-bi-blade-boosts-retina-surgery-efficiency/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/bausch-lomb-bi-blade-boosts-retina-surgery-efficiency/]]></link>
			<title>Bausch + Lomb Bi-Blade+ Boosts Retina Surgery Efficiency</title>
			<pubDate><![CDATA[Sat, 09 May 2026 06:23:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/food/lit-biosciences-launches-lit-protect-wellness-supplement/]]></guid>
			<link><![CDATA[https://cgxpwire.com/food/lit-biosciences-launches-lit-protect-wellness-supplement/]]></link>
			<title>LiT Biosciences Launches LiT Protect Wellness Supplement</title>
			<pubDate><![CDATA[Sat, 09 May 2026 06:14:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/pierre-fabre-advances-fda-path-for-tabelecleucel/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/pierre-fabre-advances-fda-path-for-tabelecleucel/]]></link>
			<title>Pierre Fabre Advances FDA Path for Tabelecleucel</title>
			<pubDate><![CDATA[Sat, 09 May 2026 05:57:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/opus-genetics-showcases-ird-gene-therapy-progress-at-arvo-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/opus-genetics-showcases-ird-gene-therapy-progress-at-arvo-2026/]]></link>
			<title>Opus Genetics Showcases IRD Gene Therapy Progress at ARVO 2026</title>
			<pubDate><![CDATA[Sat, 09 May 2026 05:55:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/whiteswell-reports-positive-delta-hf-trial-results-for-elym-system-in-acute-heart-failure/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/whiteswell-reports-positive-delta-hf-trial-results-for-elym-system-in-acute-heart-failure/]]></link>
			<title>WhiteSwell Reports Positive DELTA-HF Trial Results for eLym System in Acute Heart Failure</title>
			<pubDate><![CDATA[Mon, 11 May 2026 05:06:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/aavnergene-unveils-high-yield-aavone2-1-platform/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/aavnergene-unveils-high-yield-aavone2-1-platform/]]></link>
			<title>AAVnerGene Unveils High-Yield AAVone®2.1 Platform</title>
			<pubDate><![CDATA[Mon, 11 May 2026 04:34:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/kubtec-launches-xcell-tomorad-igrt-research-system/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/kubtec-launches-xcell-tomorad-igrt-research-system/]]></link>
			<title>KUBTEC Launches XCELL TomoRad IGRT Research System</title>
			<pubDate><![CDATA[Sat, 09 May 2026 05:50:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/aptar-pharma-advances-fda-funded-next-generation-inhaler-research/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/aptar-pharma-advances-fda-funded-next-generation-inhaler-research/]]></link>
			<title>Aptar Pharma Advances FDA-Funded Next-Generation Inhaler Research</title>
			<pubDate><![CDATA[Sat, 09 May 2026 05:27:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/halozyme-and-oruka-partner-on-hypercon-biologics-deal/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/halozyme-and-oruka-partner-on-hypercon-biologics-deal/]]></link>
			<title>Halozyme and Oruka Partner on Hypercon Biologics Deal</title>
			<pubDate><![CDATA[Sat, 09 May 2026 05:26:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/merck-publishes-science-paper-on-scalable-oral-pcsk9-inhibitor-manufacturing/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/merck-publishes-science-paper-on-scalable-oral-pcsk9-inhibitor-manufacturing/]]></link>
			<title>Merck Publishes Science Paper on Scalable Oral PCSK9 Inhibitor Manufacturing</title>
			<pubDate><![CDATA[Sat, 09 May 2026 05:15:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/harbour-biomed-receives-fda-ind-clearance-for-hbm7004-solid-tumor-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/harbour-biomed-receives-fda-ind-clearance-for-hbm7004-solid-tumor-trial/]]></link>
			<title>Harbour BioMed Receives FDA IND Clearance for HBM7004 Solid Tumor Trial</title>
			<pubDate><![CDATA[Sat, 09 May 2026 04:12:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/rznomics-announces-fda-rmat-designation-for-rz-001-in-hepatocellular-carcinoma/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/rznomics-announces-fda-rmat-designation-for-rz-001-in-hepatocellular-carcinoma/]]></link>
			<title>Rznomics Announces FDA RMAT Designation for RZ-001 in Hepatocellular Carcinoma</title>
			<pubDate><![CDATA[Sat, 09 May 2026 04:04:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/lumenis-folix-wins-2025-hair-loss-innovation-award/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/lumenis-folix-wins-2025-hair-loss-innovation-award/]]></link>
			<title>Lumenis FoLix Wins 2025 Hair Loss Innovation Award</title>
			<pubDate><![CDATA[Mon, 11 May 2026 04:22:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/cardiolrx-phase-ii-results-support-heart-disease-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/cardiolrx-phase-ii-results-support-heart-disease-therapy/]]></link>
			<title>CardiolRx Phase II Results Support Heart Disease Therapy</title>
			<pubDate><![CDATA[Fri, 08 May 2026 07:05:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/arteraai-breast-gains-fda-clearance-for-cancer-risk/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/arteraai-breast-gains-fda-clearance-for-cancer-risk/]]></link>
			<title>ArteraAI Breast Gains FDA Clearance for Cancer Risk</title>
			<pubDate><![CDATA[Fri, 08 May 2026 07:00:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/gsk-signs-1b-siranbio-sirna-cardiometabolic-deal/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/gsk-signs-1b-siranbio-sirna-cardiometabolic-deal/]]></link>
			<title>GSK Signs $1B SiranBio siRNA Cardiometabolic Deal</title>
			<pubDate><![CDATA[Fri, 08 May 2026 06:09:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/zelluna-asa-activates-first-clinical-site-for-zima-101-phase-1-solid-cancer-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/zelluna-asa-activates-first-clinical-site-for-zima-101-phase-1-solid-cancer-trial/]]></link>
			<title>Zelluna ASA Activates First Clinical Site for ZIMA-101 Phase 1 Solid Cancer Trial</title>
			<pubDate><![CDATA[Fri, 08 May 2026 06:02:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/waiv-and-daiichi-sankyo-partner-on-ai-biomarkers/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/waiv-and-daiichi-sankyo-partner-on-ai-biomarkers/]]></link>
			<title>Waiv and Daiichi Sankyo Partner on AI Biomarkers</title>
			<pubDate><![CDATA[Fri, 08 May 2026 06:00:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/moderna-publishes-positive-phase-3-clinical-data-for-mrna-1010-seasonal-influenza-vaccine-in-new-england-journal-of-medicine/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/moderna-publishes-positive-phase-3-clinical-data-for-mrna-1010-seasonal-influenza-vaccine-in-new-england-journal-of-medicine/]]></link>
			<title>Moderna Publishes Positive Phase 3 Clinical Data for mRNA-1010 Seasonal Influenza Vaccine in New England Journal of Medicine</title>
			<pubDate><![CDATA[Fri, 08 May 2026 05:50:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/rivanna-gains-fda-clearance-for-accuro-xv-ai-system/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/rivanna-gains-fda-clearance-for-accuro-xv-ai-system/]]></link>
			<title>RIVANNA Gains FDA Clearance for Accuro XV AI System</title>
			<pubDate><![CDATA[Fri, 08 May 2026 05:41:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/totus-medicines-reports-strong-phase-1b-clinical-results-for-tos-358-in-hr-her2-breast-cancer/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/totus-medicines-reports-strong-phase-1b-clinical-results-for-tos-358-in-hr-her2-breast-cancer/]]></link>
			<title>Totus Medicines Reports Strong Phase 1b Clinical Results for TOS-358 in HR+/HER2- Breast Cancer</title>
			<pubDate><![CDATA[Fri, 08 May 2026 05:37:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/bayer-pet-tracer-shows-promise-in-amyloidosis-study/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/bayer-pet-tracer-shows-promise-in-amyloidosis-study/]]></link>
			<title>Bayer PET Tracer Shows Promise in Amyloidosis Study</title>
			<pubDate><![CDATA[Fri, 08 May 2026 05:26:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/edgewise-advances-muscle-and-heart-disease-pipeline/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/edgewise-advances-muscle-and-heart-disease-pipeline/]]></link>
			<title>Edgewise Advances Muscle and Heart Disease Pipeline</title>
			<pubDate><![CDATA[Fri, 08 May 2026 05:19:29 +0000]]></pubDate>
		</item>
				</channel>
</rss>
